Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Shares Recover from Early Plunge on Non-Compliance News

NEW YORK, Feb.10 (GenomeWeb News) - Shares of Accelrys plunged 20 percent today after the company said it expected a letter of non-compliance from Nasdaq.


As GenomeWeb reported, Accelrys will delay its third quarter earnings due to ongoing discussions with the SEC regarding the company's financial restatements.


Accelrys shares were trading off $0.27, or 4.29%, at $6.03 in mid-afternoon trade.


The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.